TY - JOUR
T1 - Protective mechanism of reduced water against alloxan-induced pancreatic β-cell damage
T2 - Scavenging effect against reactive oxygen species
AU - Li, Yuping
AU - Nishimura, Tomohiro
AU - Teruya, Kiichiro
AU - Maki, Tei
AU - Komatsu, Takaaki
AU - Hamasaki, Takeki
AU - Kashiwagi, Taichi
AU - Kabayama, Shigeru
AU - Shim, Sun Yup
AU - Katakura, Yoshinori
AU - Osada, Kazuhiro
AU - Kawahara, Takeshi
AU - Otsubo, Kazumichi
AU - Morisawa, Shinkatsu
AU - Ishii, Yoshitoki
AU - Gadek, Zbigniew
AU - Shirahata, Sanetaka
PY - 2003
Y1 - 2003
N2 - Reactive oxygen species (ROS) cause irreversible damage to biological macromolecules, resulting in many diseases. Reduced water (RW) such as hydrogen-rich electrolyzed reduced water and natural reduced waters like Hita Tenryosui water in Japan and Nordenau water in Germany that are known to improve various diseases, could protect a hamster pancreatic β cell line, HIT-T15 from alloxan-induced cell damage. Alloxan, a diabetogenic compound, is used to induce type 1 diabetes mellitus in animals. Its diabetogenic effect is exerted via the production of ROS. Alloxan-treated HIT-T15 cells exhibited lowered viability, increased intracellular ROS levels, elevated cytosolic free Ca2+ concentration, DNA fragmentation, decreased intracellular ATP levels and lowering of glucose-stimulated release of insulin. RW completely prevented the generation of alloxan-induced ROS, increase of cytosolic Ca2+ concentration, decrease of intracellular ATP level, and lowering of glucose-stimulated insulin release, and strongly blocked DNA fragmentation, partially suppressing the lowering of viability of alloxan-treated cells. Intracellular ATP levels and glucose-stimulated insulin secretion were increased by RW to 2-3.5 times and 2-4 times, respectively, suggesting that RW enhances the glucose-sensitivity and glucose response of β-cells. The protective activity of RW was stable at 4 °C for over a month, but was lost by autoclaving. These results suggest that RW protects pancreatic β-cells from alloxan-induced cell damage by preventing alloxan-derived ROS generation. RW may be useful in preventing alloxan-induced type 1-diabetes mellitus.
AB - Reactive oxygen species (ROS) cause irreversible damage to biological macromolecules, resulting in many diseases. Reduced water (RW) such as hydrogen-rich electrolyzed reduced water and natural reduced waters like Hita Tenryosui water in Japan and Nordenau water in Germany that are known to improve various diseases, could protect a hamster pancreatic β cell line, HIT-T15 from alloxan-induced cell damage. Alloxan, a diabetogenic compound, is used to induce type 1 diabetes mellitus in animals. Its diabetogenic effect is exerted via the production of ROS. Alloxan-treated HIT-T15 cells exhibited lowered viability, increased intracellular ROS levels, elevated cytosolic free Ca2+ concentration, DNA fragmentation, decreased intracellular ATP levels and lowering of glucose-stimulated release of insulin. RW completely prevented the generation of alloxan-induced ROS, increase of cytosolic Ca2+ concentration, decrease of intracellular ATP level, and lowering of glucose-stimulated insulin release, and strongly blocked DNA fragmentation, partially suppressing the lowering of viability of alloxan-treated cells. Intracellular ATP levels and glucose-stimulated insulin secretion were increased by RW to 2-3.5 times and 2-4 times, respectively, suggesting that RW enhances the glucose-sensitivity and glucose response of β-cells. The protective activity of RW was stable at 4 °C for over a month, but was lost by autoclaving. These results suggest that RW protects pancreatic β-cells from alloxan-induced cell damage by preventing alloxan-derived ROS generation. RW may be useful in preventing alloxan-induced type 1-diabetes mellitus.
UR - http://www.scopus.com/inward/record.url?scp=0037560855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037560855&partnerID=8YFLogxK
U2 - 10.1023/A:1023936421448
DO - 10.1023/A:1023936421448
M3 - Article
C2 - 19003114
AN - SCOPUS:0037560855
SN - 0920-9069
VL - 40
SP - 139
EP - 149
JO - Cytotechnology
JF - Cytotechnology
IS - 1-3
ER -